Sugar-Based Excipients Market Worth $1,060.6 Million | Growth Drivers, Segmentation & Geographical Analysis

By -

Europe is the largest regional segment for the global sugar excipients market.

(EMAILWIRE.COM, August 05, 2020 ) According to the new market research report "Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast" published by MarketsandMarkets™.

The Global Sugar-Based Excipients Market is estimated to grow at a CAGR of 4.3%, to reach USD 1,060.6 Million.

Major Market Growth Drivers:

- Increasing Use of Co-Processed Excipients
- Patent Cliffs Driving the Demand for Sugar Excipients in the Generics Market
- Increasing Development of Orally Disintegrating Tablets (ODTS)
- Shifting Focus of Pharmaceutical Manufacturing to Emerging Countries

major players are continuously focusing on achieving higher market shares through expansions; agreements, alliances, and collaborations; mergers and acquisitions; new product launches; and intellectual property acquisitions.

Browse 125 market data tables and 34 figures spread through 187 pages and in-depth TOC - Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=242342136

Market Segmentation in Depth:

Based on product, the market is segmented into actual sugars, sugar alcohols, and artificial sweeteners.

Based on type, the market is segmented into powders/granules, direct compression sugars, crystals, and syrups. Similarly, on the basis of functionality, the market is segmented into fillers & diluents, flavoring agents, tonicity agents, and other functionalities.

Global Sugar Excipients Market, by Functionality;

- Fillers & Diluents
- Flavoring Agents
- Tonicity Agents
- Other Functionalities

Based on formulation, this market is segmented into oral formulations, parenteral formulations, topical formulations, and other formulations.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242342136

Geographically, the global sugar excipients market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Europe commanded a major share of the global market. Europe’s largest share is primarily attributed to the increasing investments in drug development, increasing production of generic drugs, and favorable government initiatives in the region. North America, represents the second largest market for sugar excipients.

Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), and Ashland Inc. (U.S.), held the major share of the sugar excipients market, and are expected to dominate the market during the forecast period. Other major players in this market are Associated British Foods Plc (U.K.), Cargill, Inc. (U.S.), Colorcon, Inc. (U.S.), FMC Corporation (U.S.), MEGGLE AG (Germany), and The Lubrizol Corporation (U.S.).

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more